Cosmosomes represent a next-generation topical delivery platform that bridges biomimetic lipid science with modern formulation technology. By closely mimicking the skin’s natural lipid structure, Cosmosomes ensures enhanced efficacy, safety, and consumer experience, making it a powerful and versatile solution for high-performance cosmetic and dermatological applications.

Cosmosomes are a proprietary lipid–surfactant hybrid topical drug and cosmetic delivery technology engineered to enhance the performance of topical formulations. The technology is developed using a synergistic combination of polysorbate, glyceryl monooleate (GMO), glycerine, and lecithin, all of which are well established for their skin compatibility and functional performance. This advanced delivery platform is designed to improve skin penetration, formulation stability, hydration, and controlled delivery of active ingredients.

Cosmosomes self-assemble into a biomimetic micro to nano-structured delivery matrix composed of emulsified lipid domains, GMO-based liquid crystalline phases, and lecithin-derived phospholipid bilayers. This unique structural organization closely mimics the natural lipid architecture of the skin, particularly the intercellular lipid matrix of the stratum corneum, resulting in superior skin affinity and enhanced delivery of both hydrophilic and lipophilic actives.

Upon topical application, Cosmosomes spread uniformly across the skin surface to form a non-occlusive, breathable film. Glycerine provides immediate and long-lasting hydration, improving skin softness and elasticity, while non-ionic polysorbates ensure formulation stability, smooth texture, and consistent performance.